You are here: Value of Medical Imaging

  • 01.20.11

    FDA Plans to Improve Review Path for Medical Devices

    Diagnostic Imaging | Sara Michael

    The FDA this week outlined a plan to improve the path to market for medical devices, including streamlining the review for low-risk devices and clarifying when clinical data should be submitted.

Connect with Us Online

  • Twitter
  • Facebook
  • YouTube
  • Flickr